Drug
GW274150
GW274150 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
1
20%
Ph phase_2
4
80%
Phase Distribution
1
Early Stage
4
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
4(80.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (20.0%)
Phase 24 (80.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_1
Study With GW274150 In Patients With Mild Asthma
NCT00273013
completedphase_2
Study Of 90mg Of GW274150 In Subjects Over 50 Years, Who Have Rheumatoid Arthritis (RA)
NCT00370435
completedphase_2
Use Of GW274150 In The Prophylactic Treatment Of Migraine
NCT00242866
completedphase_2
A Study To Investigate GW274150 Or Prednisolone In Rheumatoid Arthritis Taken Repeatedly For 28 Days.
NCT00379990
completedphase_2
An Adaptive Design Trial Of GW274150 In The Treatment Of Acute Migraine
NCT00319137
Clinical Trials (5)
Showing 5 of 5 trials
NCT00273013Phase 1
Study With GW274150 In Patients With Mild Asthma
NCT00370435Phase 2
Study Of 90mg Of GW274150 In Subjects Over 50 Years, Who Have Rheumatoid Arthritis (RA)
NCT00242866Phase 2
Use Of GW274150 In The Prophylactic Treatment Of Migraine
NCT00379990Phase 2
A Study To Investigate GW274150 Or Prednisolone In Rheumatoid Arthritis Taken Repeatedly For 28 Days.
NCT00319137Phase 2
An Adaptive Design Trial Of GW274150 In The Treatment Of Acute Migraine
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5